Other Male Health Disorders - Pipeline Review, H2 2012

Other Male Health Disorders - Pipeline Review, H2 2012

Global Markets Direct's, 'Other Male Health Disorders - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Other Male Health Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Other Male Health Disorders. Other Male Health Disorders - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Other Male Health Disorders.
- A review of the Other Male Health Disorders products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Other Male Health Disorders pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Other Male Health Disorders.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Other Male Health Disorders pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

To purchase and know more about this market research reports please visit: http://www.marketresearchreports.com/global-markets-direct/other-male-health-disorders-pipeline-review-h2-2012 

Gram-Negative Bacterial Infections - Pipeline Review, H2 2012

Gram-Negative Bacterial Infections - Pipeline Review, H2 2012

Global Markets Direct's, 'Gram-Negative Bacterial Infections - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Gram-Negative Bacterial Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Gram-Negative Bacterial Infections. Gram-Negative Bacterial Infections - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Gram-Negative Bacterial Infections.
- A review of the Gram-Negative Bacterial Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Gram-Negative Bacterial Infections pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Gram-Negative Bacterial Infections.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Gram-Negative Bacterial Infections pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

To purchase and know more about this market research reports please visit: http://www.marketresearchreports.com/global-markets-direct/gram-negative-bacterial-infections-pipeline-review-h2-2012 

Cardiovascular Disease - Pipeline Review, H2 2012

Cardiovascular Disease - Pipeline Review, H2 2012

Global Markets Direct's, 'Cardiovascular Disease - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Cardiovascular Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cardiovascular Disease. Cardiovascular Disease - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Cardiovascular Disease.
- A review of the Cardiovascular Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Cardiovascular Disease pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Cardiovascular Disease.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Cardiovascular Disease pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

To purchase and know more about this market research reports please visit: http://www.marketresearchreports.com/global-markets-direct/cardiovascular-disease-pipeline-review-h2-2012 

Overview on European Orthopedic Trauma Device Market

According to the report, the European orthopedic trauma device market includes plates and screws, intramedullary nails, hip intramedullary nails, compression hip screws, cannulated screws and external fixation devices. Due to cuts to reimbursement and a continued rise in public tendering, all of these segments were negatively affected by the European sovereign debt crisis in 2011.

Key features of the report

• This report provides a forecast of European medical devices market of all the European counties which include Germany, France, U.K., Italy, Spain, Benelux, Scandinavia, Austria, Switzerland, Portugal for the period of 10 years i.e. from 2009- 2019 . 
• This report provides information on analysis and also evaluates the current state of the market which includes existing and potential markets, product average selling prices, and unit volumes. In addition, the report provides highlights on the trends and technologies that will affect the future of each market segment and prepares a critical assessment of such market drivers and limiters based on bottom up approach, which includes primary and secondary research methods. 
• The report contains in-depth information on various topics such as competitor analysis, identified strategic opportunities, market overview by segment & country, trend analysis by segment & country, Internal Fixation, External Fixation and many more.
• The report also contains detailed information some of the European companies in medical devices industry namely Synthes, Orthofix, Biomet, Konigsee Implantate, Stryker, aap Implantate AG, DePuy, Acumed, Aesculap, Smith & Nephew, Zimmer, Axomed, Biotech Group, citieffe, FH Orthopedics, Gruppo Bioimpianti, Gexfix, Integra LifeSciences, Intrauma, LINK, Osteotec, Small Bone Innovations, and Tantum AG.

To purchase and know more about this market research reports please visit:  http://www.marketresearchreports.com/idata-research/european-markets-orthopedic-trauma-devices

Overview on Latin American Dental Implant Market

Latin American Markets for Dental Implants, Final Abutments and Computer Guided Surgery

As per the reports, the total Latin American dental implant and final abutment market was valued at over $226 million in 2011.

According to the reports, the dental implant market is divided into procedure type, shape, connection type, and application. The procedure type is segmented into the one-stage procedure implants, two-stage procedure implants, and immediate loading procedure implants. Dental implants vary in shape i.e. either parallel wall threaded implants or tapered threaded implants.

Inquire About This Report: LatinAmerican Markets for Dental Implants, Final Abutments and Computer GuidedSurgery

Dental implants are also segmented based on connection type, which are either internal, external or single-unit implants. Dental implants are divided by application type as either single-tooth applications, multi-unit bridge applications or denture applications. The final abutment market is divided by fabrication process into stock abutments, custom abutments and CAD/CAM abutments.

 Key features of the report:

• This report provides a forecast of Latin America dental implant market for a period of 10 years between 2008 – 2018 for Mexico, Brazil, and Argentina.
•  The report contains in-depth information about various topics such as competitor analysis, identified strategic opportunities, market overview by segment & country, root-form dental Implants, mini dental implants, dental implant shapes and many more.
• This report provides information on analysis and also evaluates the current state of the market which includes existing and potential markets, product average selling prices, and unit volumes. In addition, the report provides highlights on the trends and technologies that will affect the future of each market segment and prepares a critical assessment of such market drivers and limiters based on bottom up approach, which includes primary and secondary research methods.  
• The report also contains information on some companies of the Latin American dental implant market which include Neodent, B&W, Nobel Biocare, Straumann, Biomet, 3i, BioHorizons, Bicon, BioHorizons, Implant Direct, Keystone Dental (Lifecore), Odontit, Q-Implant, Rosterdent, Titanium Fix, Zimmer Dental, BTI, MIS Implants, SIN and Conexao.

Overview on U.S. Medical Devices Market 2012

Overview on U.S. Medical Devices Market 2012 

As per the reports, the U.S. market in 2012 for cosmetic surgery, facial aesthetics and medical laser devices was valued over $3 billion, with an increase of almost 10% from the preceding year.
In 2012, the U.S. market for cosmetic surgery, facial aesthetic and medical laser devices is composed of the botulinum toxin A market, dermal filler market, augmentation and reconstructive implant market, fat-reduction device market, and aesthetic laser and light device market. Because of augmentation and reconstructive implant market, there was a growth in this market. 
According to the reports, in 2012, the top three contributors were the botulinum toxin A market, augmentation and reconstructive implant market, and dermal filler market. The growth in this market is mainly due to mainstream media influence on public perception of the importance of youthful appearance and beauty, and other contributing factors such as the aging population and obesity in the U.S.

To purchase and know more about this market research reports please visit: U.S.Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices Market

Key features of the report:

• This report provides a forecast of U.S medical devices market for the period of 10 years i.e. from 2009- 2019.
• This report provides information on analysis and also evaluates the current state of the market which includes existing and potential markets, product average selling prices, and unit volumes. It also highlights the opportunities and potential hazards involved, and also provide strategies for successfully navigating the market landscape. In addition, the report provides highlights on the trends and technologies that will affect the future of each market segment and prepares a critical assessment of such market drivers and limiters based on bottom up approach, which includes primary and secondary research methods. 
• The report also contains detailed information on various topics which include competitor analysis, identified strategic opportunities, market overview by segment & country, trend analysis by segment & country, market drivers & limiters, mergers & acquisitions, customer feedback and market monitoring, botulinum toxin, hyaluronic acid dermal filler, augmentation and reconstructive implants and many more. 
• The report contains company details of major medical devices industry players in U.S namely Allergan, Inc, Medicis Pharmaceutical Corporation, Medical Device (MD) Resource Corp. Palomar Medical Technologies, Implantech, etc.

Forecast of Latin America biomaterial market to 2019

Latin American Markets for Dental Bone Graft Substitutes and Other Biomaterials

According to the report, the total Latin American dental bone graft substitute and other biomaterials market increased as compared to the previous year. The market includes dental bone graft substitute materials and dental membranes. The growth of the dental bone grafting market is very closely linked to the growth of the dental implant industry. Most of bone grafting procedures were performed with dental implant applications in 2012.

To purchase and know more about this market research report please visit:  LatinAmerican Markets for Dental Bone Graft Substitutes and Other Biomaterials

Key features of the report :

• This report provides a forecast of Latin America biomaterial market for a period of 10 years between 2009 – 2019 for Mexico, Brazil, and Argentina.
• The report contains in-depth information about various topics such as competitor analysis, identified strategic opportunities; market Overview by segment & country, trend analysis by segment & country, dental implant procedures, periodontal procedures and many more.
• This report provides information on analysis and also evaluates the current state of the market which includes existing and potential markets, product average selling prices, and unit volumes. In addition, the report provides highlights on the trends and technologies that will affect the future of each market segment and prepares a critical assessment of such market drivers and limiters based on bottom up approach, which includes primary and secondary research methods.
• The report also contains detailed data on some of the Latin American companies in biomaterial market which include Geistlich, Zimmer, UNC, Alpha-Bio, BIOMET 3i, BioHorizons, B&W, Bicon, KOKEN, MIS Implants, Odontit, Osteogenics, S.I.N. Implants and Tissue Banks.